hMSH5 is a nucleocytoplasmic shuttling protein whose stability depends on its subcellular localization by Lahaye, François et al.
hMSH5 is a nucleocytoplasmic shuttling protein
whose stability depends on its subcellular
localization
Franc ¸ois Lahaye
1, Franc ¸oise Lespinasse
1, Pascal Staccini
2, Lucile Palin
1,
Ve ´ronique Paquis-Flucklinger
1 and Sabine Santucci-Darmanin
1,*
1FRE 3086 ‘Instabilite ´ ge ´ne ´tique: Maladies rares et cancers’, Universite ´ de Nice Sophia-Antipolis, CNRS and
2Stic, Universite ´ de Nice-Sophia Antipolis, Faculte ´ de Me ´decine, Avenue de Valombrose 06107, Nice Cedex 2,
France
Received April 24, 2009; Revised February 2, 2010; Accepted February 3, 2010
ABSTRACT
MSH5 is a MutS-homologous protein required for
meiotic DNA recombination. In addition, recent
studies suggest that the human MSH5 protein
(hMSH5) participates to mitotic recombination and
to the cellular response to DNA damage and thus
raise the possibility that a tight control of hMSH5
function(s) may be important for genomic stability.
With the aim to characterize mechanisms poten-
tially involved in the regulation of hMSH5 activity,
we investigated its intracellular trafficking pro-
perties. We demonstrate that hMSH5 possesses
a CRM1-dependent nuclear export signal (NES)
and a nuclear localization signal that partici-
pates to its nuclear targeting. Localization analysis
of various mutated forms of hMSH5 by confocal
microscopy indicates that hMSH5 shuttles between
the nucleus and the cytoplasm. We also provide
evidence suggesting that hMSH5 stability depends
on its subcellular compartmentalization, hMSH5
being much less stable in the nucleus than in the
cytoplasm. Together, these data suggest that
hMSH5 activity may be regulated by nucleocyto-
plasmic shuttling and nuclear proteasomal degrada-
tion, both of these mechanisms contributing to the
control of nuclear hMSH5 content. Moreover, data
herein also support that in tissues where both
hMSH5 and hMSH4 proteins are expressed, hMSH5
might be retained in the nucleus through masking of
its NES by binding of hMSH4.
INTRODUCTION
Despite being a member of the DNA mismatch repair
(MMR) family of proteins, the MutS homolog MSH5
does not appear to participate in mismatch repair in mam-
malian cells. Instead, this protein, together with a second
MutS-like protein called ‘MSH4’, is essential for meiosis.
Several lines of evidence strongly suggest that the
MSH4-MSH5 heterodimer is essential for the processing
and/or the stabilization of meiotic DNA recombination
intermediates (1–3). Nevertheless, recent ﬁndings also
support the view that human MSH4 and MSH5 proteins
might be involved in processes other than meiotic recom-
bination and might even function independently of one
another (4).
These proposals are notably based on expression data
which showed that MSH4 and MSH5 transcripts are
present in human non-meiotic tissues (4), and that
hMSH4 exhibits a limited expression proﬁle whereas
hMSH5 mRNA are detected in a broad spectrum of
tissues (5–10). Protein–protein interaction data and func-
tional studies also strengthen the assumption that hMSH4
and hMSH5 proteins are involved in various cellular pro-
cesses through their interactions with diﬀerent partners.
hMSH4 interacts with VBP1 (9), which is suspected of
being involved in microtubule assembly (11) and which
competes with hMSH5 for binding to hMSH4 (9).
Conversely, hMSH5 has been shown to interact with
c-Abl (12), a tyrosine kinase implicated in the regulation
of DNA recombination and DNA damage signaling. This
interaction facilitates the activation of c-Abl tyrosine
kinase and induces the tyrosine phosphorylation of
hMSH5 in response to ionizing radiation, which in turn
favors the dissociation of the hMSH4-hMSH5
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promotes ionizing radiation-induced apoptosis (13).
RNAi-mediated hMSH5 silencing reduces apoptosis in
irradiated cells and conversely, the overexpression of
hMSH5 alone is suﬃcient to increase the radiation-
induced apoptotic response (13), which implies that
hMSH4 is not implicated in this process. hMSH5 has
also been found to interact with HJURP and MRE11 in
a human cell line derived from a lung adenocarcinoma
(14). HJURP is a Holliday junction binding protein (14),
and MRE11 is a crucial enzyme for DNA double-strand
break repair (15). Taken together, these ﬁndings strongly
suggest that hMSH5 is involved in DNA damage signal-
ing and mitotic DNA recombination and, thereby, in the
maintenance of genomic stability. Furthermore, the
dimerization of hMSH5 and hMSH4 would appear not
to be required for all hMSH5 functions. These observa-
tions, in addition to the fact that the hMSH5 locus
(6p21.33) has been identiﬁed as a new locus for suscepti-
bility to lung cancer (16), has emphasized the necessity for
further investigating the function(s) exerted by the
hMSH5 protein and the mechanisms involved in the reg-
ulation of its various, as-yet undeﬁned activities.
Shuttling between the nucleus and the cytoplasm has
emerged in the last few years as an important regulatory
mechanism for multifunctional proteins involved in DNA
repair pathways and maintenance of genetic stability,
such as BRCA1, BRCA2, p53 and FANCA (17–19).
Interestingly, a previous study has led to the proposal
that nucleocytoplasmic traﬃcking may constitute a
regulatory mechanism for MSH4 functions (20). As a
ﬁrst step toward analyzing the mechanisms involved in
the control of hMSH5 functions, we investigated the
cellular traﬃcking properties of hMSH5. Traﬃcking
of most proteins larger than 60kDa through nuclear
pore complexes is an active process mediated by
nuclear import and export receptors, which bind to
nuclear localization signals (NLS) or nuclear export
signals (NESs) within cargo proteins (21). Classical NLS
sequences contain one or two clusters of positively
charged amino acids (22). The most common NES are
characterized by short hydrophobic leucine-rich regions
that are generally recognized by the export receptor
CRM1 (23).
Here, we provide the ﬁrst evidence that hMSH5 is a
nucleocytoplasmic shuttling protein that actively enters
and exits the nucleus. We demonstrate that hMSH5
contains a conserved classical monopartite NLS and a
conserved C-terminal NES motif that mediate nuclear
export through the CRM1-dependent pathway. In
addition, our data indicate that the stability of hMSH5
is related to its subcellular localization. Our experiments
suggest that the half-life of hMSH5 is markedly reduced
in the nucleus and that this is dependent on the
proteasome. Therefore, our results raise the possibility
that hMSH5 nuclear activity may be regulated by both
nucleocytoplasmic shuttling and proteasomal degrada-
tion. Finally, we provide new insights into the reciprocal
regulation of the subcellular localizations of hMSH5 and
hMSH4 through their dimerization.
MATERIAL AND METHODS
Cell culture and transfections
HeLa cervical carcinoma cells were from the American
Type Culture Collection and maintained in Eagle’s
Minimum Essential Medium (EMEM) supplemented
with 10% fetal calf serum and antibiotics. Cells seeded
onto 60-mm sterile dishes or glass coverslips in culture
dishes were transfected by using either a standard
calcium phosphate method or FuGene HD reagent
according to the manufacturer’s instructions (Roche
Applied Science). Twenty-four hours after transfection,
Leptomycin B (LMB, Biomol) was added for 6h (except
when indicated) at a ﬁnal concentration of 18.5nM to
inhibit CRM1-dependent nuclear export. The proteasome
inhibitor MG132 (Biomol) and the protein synthesis
inhibitor cycloheximide (Sigma–Aldrich) were added to
transfected cells for the indicated periods of time at con-
centration of 10mM and 50mg/ml, respectively. The
actinomycin D (Sigma-Aldrich) was used at a ﬁnal con-
centration of 5mg/ml.
Antibodies
Mouse monoclonal anti-GFP (B-2) and goat
polyclonal anti-Lamin B (C-20) were from Santa Cruz
Biotechnology; mouse monoclonal anti-Flag (M2) and
mouse monoclonal anti-ß-tubulin were purchased from
Sigma–Aldrich, mouse monoclonal anti-Hsp90a and
mouse monoclonal anti-Poly(ADP-Ribose) Polymerase-1
(PARP-1) were from Calbiochem. Secondary antibodies
used in western blotting experiments were either goat
anti-mouse immunoglobulin (IgG) or rabbit anti-goat
IgG, conjugated with horseradish peroxydase (Dako).
Plasmid constructions and mutagenesis
pEGFP-C1-hMSH5 and the plasmid encoding
DsRed-hMSH4 have been described previously (20). To
generate the GFP-N1-hMSH5 protein construct, the
hMSH5 cDNA was ampliﬁed by polymerase chain
reaction (PCR) with primers containing terminal restric-
tion sites. The resulting products were digested and ligated
in frame into the XhoI–BamHI sites of pEGFP-N1
(Clontech). For the expression of hMSH5 deletion
mutants as GFP fusion proteins, speciﬁc regions of the
hMSH5 cDNA were PCR-ampliﬁed, digested and cloned
between XhoI and BamHI sites of pEGFP-C1 (Clontech).
The pFLAG-hMSH5 plasmid was generated by insertion
of the hMSH5 coding sequence, which was ampliﬁed by
PCR, into BamHI/PstI sites of the pCMV-3Tag-1A
vector (Stratagene).
The plasmids pRev(1.4)-GFP and pRev(1.4)-NES-GFP
were kind gifts from Dr. Beric Henderson (Westmead
Institute for Cancer Research, Australia) and have been
described elsewhere (24). Oligonucleotides (50-GATCCAC
AGACATTAGTGGATAAGTTTATGAAACTGGATTT
GGAAGATCCTAACCTGGACTTA-30 and 50-CCGGT
AAGTCCAGGTTAGGATCTTCCAAATCCAGTTTCA
TAAACTTATCCACTAATGTCTGTG-30) were annealed
to produce a double-stranded DNA fragment ﬂanked by
BamH1 and AgeI termini and that encodes the putative
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fragment was inserted between the Rev(1.4) and the
GFP coding sequences of pRev(1.4)-GFP to produce
pRev(1.4)-hMSH5-NES-GFP. The vector pRev(1.4)-
hMSH5-NES
mut-GFP containing the hMSH5 NES
bearing mutations in the four consensus residues
(L802A, F806A, L809A and L811A) was constructed
by using the same strategy and the following
oligonucleotides 50-GATCCACAGACAGCAGTGGATA
AGGCTATGAAAGCGGATGCGGAAGATCCTAACC
TGGACTTA-30 and 50-CCGGTAAGTCCAGGTTAGG
ATCTTCCGCATCCGCTTTCATAGCCTTATCCAC
TGCTGTCTGTG-30.
The pHM830 plasmid encodes the GFP-b-galactosidase
fusion protein (called GFP-bgal in the following text). The
pHM840 vector allows the expression of the GFP-(SV40-
LT)NLS-b-galactosidase protein, referred to as GFP-
(SV40-LT)NLS-bgal. Both pHM830 and pHM840 were
kindly provided by Dr Thomas Stamminger (Institute
for Clinical and Molecular Virology, University Hospital
Erlangen, Germany) and have been described previously
(25). hMSH5 cDNA fragments corresponding to residues
1–405, 410–549, 508–558, 550–750 and 700–834 of the
protein were obtained by PCR using primers
incorporating a NheI site at the 50-end and a SacII site
at the 30-end. The resulting fragments were inserted into
the NheI/SacII-digested pHM830 plasmid. The construct
containing the putative NLS motif of the hMSH5 protein
was generated by annealing two oligonucleotides (50-CGC
GGGGCCAGGATGAGAAAAAGCGAAGACTGGTG
GGCTGTAGAG-30 and 50-CTCTACAGCCCACCAGT
CTTCGCTTTTTCTCATCCTGGCCCCGG-30) and
inserting the resulting double-stranded DNA fragment in
frame into the NheI–SacII sites of pHM830. The putative
hMSH5 NLS sequence is indicated by boldface letters.
The various full-length GFP-hMSH5-NES and
GFP-hMSH5-NLS punctual mutants were generated
using the QuikChange-XL Site-Directed Mutagenesis kit
(Stratagene). Oligonucleotide sequences used for PCR
ampliﬁcation and for site-directed mutagenesis are avail-
able upon request. All constructs described above were
veriﬁed by DNA sequencing.
Fluorescence microscopy and quantitation of subcellular
distribution
Cells transiently transfected with GFP and/or Ds-Red
fusion constructs, were grown on glass coverslips and
treated or not with leptomycin B as described above.
Thereafter, cells were ﬁxed in 0.2M phosphate buﬀer
(pH 7.4) with 4% paraformaldehyde and mounted on
slides with Mowiol 4-88 reagent (Calbiochem) containing
DAPI (40,6-diamidino-2-phenylindole, Sigma–Aldrich) in
order to stain nuclei. Cells were visualized with a Zeiss
LSM 510 META confocal laser scanning microscope by
using a 63  oil-immersion objective, appropriate ﬁlter
sets, argon (488nm) and helium-neon (543nm) and a
blue diode (405nm) lasers. Images of ﬂuorescent cells
were captured within the linear range of the digital
camera (CCD camera, model C 4880; Hamamatsu
Phototonics).
For full-length, truncated or point-mutated hMSH5
fusion proteins (Figures 1–3, 6 and 8) and for DsRed-
hMSH4 (Figure 8), quantitative analyses were performed
according to previously described procedures (26–29),
with slight modiﬁcations. Brieﬂy, for each cell analyzed,
AxioVision Release 4.5 software (Zeiss) was used to
quantify GFP or DsRed ﬂuorescence intensities from a
confocal z-section that cuts through the middle of the
nucleus: the mean ﬂuorescence in the entire cell area
(nuclear plus cytoplasmic or N+C) and the mean ﬂuores-
cence in the nucleus area (N), as delineated by DAPI
staining, were determined after subtraction of the back-
ground signal. For each cell, these measurements were
used to calculate the percent ﬂuorescence value for the
nuclear compartment (N/N+C ratio). As many as 30–35
cells were analyzed for each construct and each condition
(incubation of transfected cells in the absence or presence
of leptomycin B). This was repeated three times and the
mean value of the N/N+C ratio with standard deviation
was calculated for each protein and each condition from
these three independent experiments. Comparison of mean
values used a t-test procedure and was performed with
Minitab 13 software, a value of 0.05 was chosen as the
level of signiﬁcance.
To evaluate the activity of the hMSH5 nuclear export
sequence when this motif was fused to an heterologous
protein (Figure 4), quantitative analyses were performed
as described in (24). Brieﬂy, the subcellular distribution of
each pRev(1.4)-GFP-derived construct was analyzed by
evaluating the percentage of cells with either exclusively
nuclear (N), nuclear and cytoplasmic (NC) or exclusively
cytoplasmic (C) GFP ﬂuorescence. At least 200 cells were
scored for each transfection assay. The mean and standard
deviation values from three independent transfection
experiments were then calculated for each pRev(1.4)-
GFP-derived construct. The same procedure was used to
quantify the subcellular distribution of the various
pHM830-derived constructs used to characterize potential
nuclear localization signals within hMSH5 (Figure 5).
In vivo export pRev1.4 assay
HeLa cells were transfected with either pRev(1.4)-GFP,
pRev(1.4)-NES-GFP or pRev(1.4)-MSH5-NES-GFP. At
24h after transfection, cells were treated with either
cycloheximide and actinomycin D or cycloheximide and
LMB. The cycloheximide was used in these experiments to
ensure that cytoplasmic GFP-fusion proteins arise from
nuclear export and not from new protein synthesis. As a
control, we used cells treated only with cycloheximide.
After 3h of treatment, the cells were observed under the
ﬂuorescence microscope and the subcellular localization of
the GFP-fusion proteins was analyzed as described above.
Cell lysis, immunoprecipitations and western blot analysis
Twenty-four hours after transfection, cells were lysed as
previously described (20). The resulting lysates were sub-
jected to either western blotting analysis or immunopre-
cipitation as described in a previous study (20).
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Cytosolic and nuclear protein fractions from transfected
cells were prepared using the ProteoExtract subcellular
proteome extraction kit (Calbiochem), according to the
manufacturer’s instructions. These fractions were then
denaturated in Laemmli sample buﬀer and equal cellular
amounts of each fraction were separated on a 7.5% SDS-
polyacrylamide gel and submitted to immunoblotting with
the indicated antibodies. The purity and protein content of
fractionated extracts were assessed by immunoblotting for
Figure 1. Subcellular distribution of hMSH5 fusion proteins. (A) The intracellular distribution of the hMSH5 protein fused to an N-terminal
GFP-tag (GFP-C1-hMSH5), a C-terminal GFP-tag (GFP-N1-hMSH5) or an N-terminal FLAG-tag (FLAG-hMSH5) was examined in HeLa
cells by laser confocal ﬂuorescence (GFP-tagged proteins) or immunoﬂuorescence (FLAG-hMSH5) microscopy. The images shown are representative
of all the transfected cells. Upper panels show the distribution of the indicated fusion protein. Cells were counterstained with DAPI to visualize
nuclei (lower panels). (B) HeLa cells expressing the indicated proteins were collected and fractionated into cytosolic (C) and nuclear extracts (N).
Equal cell amounts from cytosolic and nuclear extracts were immunoblotted with anti-GFP or anti-FLAG antibodies, as indicated. The eﬃciency of
fractionation was veriﬁed by staining for HSP90a as a cytoplasmic marker, and PARP-1 as a nuclear marker. (C) HeLa cells transiently expressing
the indicated fusion proteins were incubated without (–LMB) or with leptomycin B (+LMB) for 6h. The localization of hMSH5 fusion proteins was
determined by ﬂuorescence and immunoﬂuorescence microscopy. Left panels show representative micrographs. The right panel presents a quanti-
tative analysis of the localization data. For each cell, the ﬂuorescence intensities in the entire cell area and in the nuclear area were evaluated, as
detailed in ‘Material and Methods’ section and the nuclear ﬂuorescence was calculated as a percentage of total (nuclear plus cytoplasmic) cell
ﬂuorescence (N/N+C). As many as 30–35 cells were analyzed per experiment, for each protein and each condition (±LMB). The graph represents
the mean N/N+C values with standard deviations (error bars) across at least three independent experiments.
3658 Nucleic Acids Research, 2010,Vol.38, No. 11either b-tubulin or HSP90a that localize speciﬁcally to
the cytoplasmic compartment and for either Lamin B or
PARP-1 that are found exclusively in the nuclear
compartment.
RESULTS
hMSH5 subcellular distribution is leptomycin B sensitive
We have previously shown that the GFP-hMSH5 fusion
protein (also called GFP-C1-hMSH5 herein) is mainly
cytoplasmic, and that its subcellular localization is sensi-
tive to leptomycin B (LMB), a speciﬁc inhibitor of
CRM1-dependent nuclear export (20). To further
explore these observations and to exclude the possibility
that the intracellular distribution of hMSH5 has been
aﬀected by N-terminal GFP tagging, we analyzed by ﬂu-
orescence microscopy the subcellular localization of
hMSH5 fused either to a C-terminal GFP tag (GFP-
N1-hMSH5) or to an N-terminal tag consisting of three
FLAG octapeptides (FLAG-hMSH5). This was done in
transfected HeLa cells (Figure 1A), U2OS cells and WI38
human primary ﬁbroblats (data not shown). Both
GFP-N1-hMSH5 and FLAG-hMSH5 appeared to
localize predominantly within the cytoplasmic compart-
ment and exhibited a subcellular distribution similar to
that of GFP-C1-hMSH5. These observations were con-
ﬁrmed by western blot analysis of fractionated cell
lysates of HeLa cells expressing the various hMSH5
fusion proteins (Figure 1B). Similar to GFP-C1-hMSH5,
both GFP-N1-hMSH5 and FLAG-hMSH5 underwent
nuclear accumulation following leptomycin B treatment
of transfected HeLa cells (Figure 1C). Quantiﬁcation of
the nuclear localization of the hMSH5 fusion proteins
further showed that GFP-C1-hMSH5, GFP-N1-hMSH5
and FLAG-hMSH5 accumulated in the nucleus to
similar extents, upon LMB addition.
These data conﬁrmed that inhibition of the CRM1
transport pathway results in a partial relocalization of
hMSH5 when expressed in somatic cells. In addition,
they suggested that neither the nature of the tag nor its
position at the N- or C-terminus has an eﬀect on hMSH5
nucleocytoplasmic distribution and relocalization in
response to LMB. This indicated that the fusion proteins
described above could be used to identify potential local-
ization signals in hMSH5 required for its nuclear export
and import.
The C-terminal part of hMSH5 exhibits a nuclear
export activity
These results prompted us to search whether hMSH5
possesses sequences mediating CRM1-dependent nuclear
export. CRM1 recognizes its cargo proteins by binding
directly to NESs composed of a short sequence containing
regularly spaced leucine or other large hydrophobic
amino acids (30). hMSH5 contains several leucine-rich
sequences which conform more or less to the NES con-
sensus -x2–3--x2–3--x- (where  is L, I, V, F or M,
and x is any residue) (20). To address the potential con-
tribution of these sequences to hMSH5 nuclear export,
deletion constructs were generated as GFP-fused forms
(Figure 2A). The resulting GFP-hMSH5 truncated
proteins were analyzed by western blot analysis, all of
them exhibited the expected size (Figure 2B). We then
examined their subcellular distribution and their
behavior upon LMB treatment (Figure 2C). The level of
nuclear localization (N/N+C ratio) was determined for
each truncation mutant, as described in ‘Material and
Methods’ section (Figure 2D).
We ﬁrst observed that the GFP-hMSH5-[1–524] (also
termed 1) and GFP-hMSH5-[522–834] (or 2)
mutants were able to enter the nucleus, suggesting that
domains involved in hMSH5 nuclear import are present
in the N- and C-terminal half of the protein. We then
noticed that the 2 mutant was mainly cytoplasmic in
the absence of LMB treatment and that it accumulated
in the nucleus of HeLa cells to the same extent as the
wild-type protein after addition of LMB. By contrast,
the 1 mutant was markedly more nuclear than the wild
type protein and mostly unperturbed by LMB treatment.
The behavior of these two mutants suggested that the
N-terminal half of the hMSH5 protein does not exhibit
a nuclear export activity and that domains involved in
CRM1 dependent nuclear export of hMSH5 are located
between residues 522 and 834. The truncation GFP-
hMSH5-[1–793] (or 3) mutant accumulated in the
nucleus to a higher extent than the full-length protein
and was poorly responsive to LMB treatment. These
results further suggested that a nuclear export activity
resides within the last 41 amino acids of hMSH5.
Identiﬁcation of a conserved NES within the C-terminus
of hMSH5
Visual examination of the C-terminal amino acid sequence
of hMSH5 (794–834aa) revealed a cluster of hydrophobic
residues (802-LVDKFMKLDL-811), conserved among
vertebrates and in Arabidopsis thaliana, that perfectly
matches the NES consensus sequence (Figure 3A).
Moreover, the NetNES 1.1 prediction program (31)
identiﬁed L811, L816 and L818 as residues potentially
involved in a nuclear export activity (Figure 3A). These
observations prompted us to perform site-directed
mutagenesis of one, two or four bulky hydrophobic
residues located between aa 802 and aa 818, in the
context of the full-length hMSH5 protein (Figure 3B). It
is expected that inactivation of a NES results in increased
nuclear localization and loss of responsiveness to LMB
treatment. The expression of the various GFP-hMSH5
mutants in HeLa transfected cells was evaluated by
western blot analysis (Supplementary Figure S1) and
their subcellular distribution was analyzed (Figure. 3C).
We noticed that alanine replacement of both L816 and
L818 (M1 mutant) was without eﬀect on the
nucleocytoplasmic distribution pattern of hMSH5. By
contrast, converting the leucine 802 to alanine led to a
slight but signiﬁcant nuclear enrichment of the resulting
M2 mutant compare with the wild-type protein. A more
important increase in nuclear localization was observed
when F806, L809 or L811 was mutated to alanine (M3
to M5 mutants, respectively). The mutation of both
L809 and L811 (M6 mutant) or of all large hydrophobic
Nucleic Acids Research, 2010,Vol.38, No. 11 3659residues located between aa 802 and 811 (M7 mutant) did
not further enhance the nuclear accumulation. Taken
together, these observations suggested that the
802-LVDKFMKLDL-811 motif is a functional NES
and that residues L802, F806, L809 and L811 contribute
to its nuclear export activity. To conﬁrm that these
conserved hydrophobic amino acids are involved in
CRM1-dependent nuclear export of hMSH5, we
examined the subcellular localization of the various
GFP-hMSH5 mutants after LMB treatment
(Supplementary Figure S2). We then calculated, for
the wild-type protein and for each mutant (M1–M7), the
fold accumulation in the nucleus induced by LMB as the
ratio [N/N+C (+LMB)]/[N/N+C ( LMB)] (Figure
3D). As expected, the M1 mutant exhibited the same sen-
sitivity to LMB treatment as the wild-type protein, while
mutations of hydrophobic residues within the 802–811-aa
domain rendered the resulting mutants less responsive to
LMB. In particular, LMB had only a slight eﬀect on the
intracellular distribution of the M7 mutant in which all the
hydrophobic amino acids of the NES have been converted
to alanine. These data suggested that hMSH5 802–811-aa
domain is a functional leucine-rich NES required for
CRM1-dependent nuclear export of hMSH5.
The hMSH5 NES exhibits an export activity in an
in vivo nuclear export assay
We next assessed whether the hMSH5 NES could confer
export when fused to other proteins, by using a
transfection-based in vivo nuclear export assay (24). This
assay consists of analyzing the intracellular distribution of
the HIV Rev(1.4) protein fused to the GFP, by ﬂuores-
cence microscopy. While the Rev wild-type protein
shuttles between the nucleus and the cytosol owing to its
strong NLS and NES, Rev(1.4) is deﬁcient in nuclear
export (32). Potential NES sequences can be inserted
into the the pRev(1.4)-GFP vector, in order to examine
their capability to restor nuclear export activity
(Figure 4A). Actinomycin D (ActD) treatment prevents
nuclear import of the Rev protein and results in
Figure 2. Mapping of hMSH5 regions that exhibit a nuclear export activity. (A) Protein structures of the GFP-hMSH5 full-length protein and of the
GFP-hMSH5 deletion mutants (1t o3) are shown. Numbers indicate the amino acid number of hMSH5. (B) Lysates from HeLa cells transfected
with the indicated deletion constructs were analyzed by western blotting with anti-GFP antibodies. Truncated fusion proteins of expected size are
marked by a star. (C) Representative ﬂuorescence microscopy images of HeLa cells expressing one of the indicated deletion mutant and treated or
not with LMB. (D) Quantitative analysis of the localization data of the GFP-hMSH5 protein (wt) and of the indicated truncated fusion proteins. The
graph shows the mean N/N+C values and standard deviations based on three independent experiments (30–35 cells per experiment were scored).
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proteins. Consequently, the use of this drug allows the
activity of very weak NESs to be detected and the
relative activity of diﬀerent NES can be evaluated by
their capability to induce a shift of the GFP signal into
the cytoplasm, in the presence (without ActD treatment)
or in the absence (with ActD treatment) of active nuclear
import. Moreover, if the tested NES is recognized by the
CRM1 exportin, the cytoplasmic accumulation of the
fusion protein is expected to be inhibited by LMB.
When the wild-type Rev NES is inserted into pRev(1.4)-
GFP, the export activity is restored to the Rev wild-type
level (24). Therefore, Rev(1.4)-NES-GFP was used as a
positive control for nuclear export in our experiments,
Figure 3. Mutational analysis of the putative hMSH5 NES. (A) The NES consensus is shown where  represents hydrophobic residues (L, I, F, V,
M) and x represents any amino acid. Alignment of the putative hMSH5 NES domain with those of other species is shown. Sequences are based on
the following accession numbers in GenBank: BAB63375 (Homo sapiens), AAD52102 (Mus musculus), XP-532080 (Canis familiaris), XP-001789888
(Bos Taurus), XP-698552 (Dario rerio), ABO69626 (Arabidopsis thaliana). Residues that ﬁt the NES consensus are boxed, those predicted to be
involved in the nuclear export activity by the NetNES 1.1 software are marked by a +. (B) Amino acids of hMSH5 NES region that were replaced
with alanine are shown. The names of the resulting mutated proteins are indicated (M1–M7). (C) Quantitative analysis of the localization data of the
wild-type GFP-hMSH5 protein (wt) and the mutants (M1–M7). HeLa cells expressing either GFP-hMSH5 or one of the mutated proteins were
examined by ﬂuorescence microscopy. The graph represents the mean N/N+C values with standard deviations of three independent experiments.
P-values were estimated using a t-test and represent the comparison of mean nuclear ﬂuorescence values between each mutant and the wild-type
protein. *P<0.001. (D) The bar graph shows the fold increase of nuclear localization induced by LMB for the wild-type hMSH5 protein and each
mutant.
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The wild-type hMSH5 NES and the hMSH5 NES
with mutations on residues L802, F806, L809 and L811
were inserted in the pRev(1.4)-GFP plasmid,
producing pRev(1.4)-MSH5NES-GFP and pRev(1.4)-
MSH5NES
mut-GFP, respectively. The subcellular
distribution of Rev(1.4)-GFP, Rev(1.4)-NES-GFP,
Rev(1.4)-MSH5NES-GFP or Rev(1.4)-MSH5NES
mut-
GFP was analyzed as described in ‘Material and
Methods’ section. Representative ﬂuorescence images
and quantitative data are shown in Figure 4B. As
expected, Rev(1.4)-GFP was found exclusively in the
nucleus in >90% of cells whatever the drug treatment.
The insertion of the Rev wild-type NES sequence
resulted in a partial cytoplasmic accumulation of the
fusion protein and this tendency was further enhanced
after addition of actinomycin D, as previously described
(24). We noticed that the insertion of the hMSH5 NES
shifted the GFP signal completely to the cytoplasm in
more than 55% of cells, even in the absence of
actimomycin D and that inhibition of nuclear import
only slightly enhanced the percentage of cells exhibiting
exclusive cytoplasmic GFP staining (56% without ActD
versus 63% after ActD treatment). It has been previously
proposed that such a behavior is characteristic of very
active NES (24). Therefore, our data raised the possibility
that the hMSH5 NES is able to display a strong nuclear
export activity. LMB treatment completely inhibited the
Figure 4. Analysis of the hMSH5 NES activity by using an in vivo nuclear export assay. (A) Schematic diagram illustrating the basis of the assay to
evaluate the activity of a potential NES. (B) HeLa cells were transfected with either pRev-1.4-GFP (Rev NES 1.4), pRev-NES-GFP (Rev NES),
pRev-MSH5NES-GFP (MSH5 NES) or pRev-MSH5NES
mut-GFP (MSH5 NES
mut). The subcellular localization of the various fusion proteins, in
cells treated with the indicated drug conditions, was analyzed by ﬂuorescence microscopy. Left panels show representative images. Right panels show
histograms presenting the percentage of cells for each condition that exhibit only cytoplasmic (C), nuclear plus cytoplasmic (NC) or exclusively
nuclear (N), GFP ﬂuorescence staining. Approximately 200 cells were scored for each transfection experiment. The data represent mean values of
three independent experiments with standard deviations.
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nuclear receptor for hMSH5. As an additional control, we
examined the subcellular distribution of the Rev(1.4)-
MSH5NES
mut-GFP protein. The ﬂuorescent pattern
of this fusion protein was similar to that of the nega-
tive control Rev(1.4)–GFP, which conﬁrmed that the
802–811-aa domain of hMSH5 possesses a nuclear
export activity that depends on the four conserved 802,
806, 809 and 811 residues.
hMSH5 possesses a weak classical monopartite NLS
We then attempted to identify the regulatory domains
involved in the nuclear targeting of hMSH5. The
best-characterized nuclear import signals comprise one
or two short stretches of basic amino acids and are
referred to as classical NLSs. Computer analysis of the
hMSH5 sequence with the PSORTII program identiﬁed
the sequence KKRR (aa 406–409) as a putative NLS.
This monopartite cluster of basic amino acid residues is
conserved among vertebrates as can be seen in a
cross-species comparison of MSH5 amino acid sequence
(Figure 5A). Visual and computer-assisted analysis failed
to identify other classical NLS within hMSH5. However,
it is noteworthy that there are a number of experimentally
deﬁned NLSs that do not match the consensus sequence of
classical NLS (33). In order to evaluate the potential
nuclear import function of the hMSH5 406-KKRR-409
motif and to search for potential non-classical nuclear tar-
geting signals within hMSH5, experiments were performed
using an established nuclear transport assay (25). A
fragment encoding the putative hMSH5 classical
(hMSH5-[404–411]) and fragments spanning the entire
open-reading frame of hMSH5 were inserted into the
NLS mapping vector pHM830. This vector allows the
expression of protein fragments fused both to the GFP
and the b-galactosidase proteins (Figure 5B). The GFP
functions as a ﬂuorescent tag, while the b-galactosidase
increases the molecular weight of the resulting fusion
proteins, ensuring that they cannot passively diﬀuse into
the nucleus. The GFP-bgal fusion protein without inserted
NLS exhibits a cytoplasmic staining (25) (Figure 5C and
D). By contrast, the GFP-bgal fusion protein containing
the NLS of SV40 LT is known to be localized almost
exclusively in the nucleus (25) and was used in our exper-
iments as a positive control for nuclear targeting (Figure
5C and D). The localization of the various fusion proteins
was examined by ﬂuorescence microscopy (Figure 5C and
D). As expected, the GFP-bgal protein was exclusively
cytoplasmic in more than 80% of transfected cells.
Insertion of hMSH5-[404–411] fragment was found to
enhance the nuclear localization of the resulting fusion
protein, albeit to a lower extent than the insertion of
SV40 LT NLS. These data indicated that the hMSH5-
[404–411] domain allows the targeting of a heterologous
protein to the nucleus, suggesting that 406-KKRR-409
motif is a functional NLS. Our observation also suggested
that this hMSH5 NLS exhibits a weak nuclear import
activity compared with SV40 LT NLS. None of the
other hMSH5 protein fragments was able to translocate
the corresponding fusion proteins to the nucleus
(Figure 5C and D). As the hMSH5-[700–834] segment
includes the NES domain, the subcellular localization of
GFP-hMSH5-[700–834]-bgal was examined before and
after inhibition of nuclear export by LMB, in order to
test the possibility that the hMSH5 NES has overcome
the activity of a potential NLS. This fusion protein
was almost exclusively cytoplasmic in both conditions
(Figure 5C and D), suggesting that the hMSH5-
[700–834] fragment does not contain a NLS. Taken
together, these results supported the view that hMSH5
does not contain nuclear targeting signal other than the
406-KKRR-409 motif. However, this seemed unlikely
since GFP-hMSH5-[522–834] has the capability to enter
the nucleus (Figure 2). One possible explanation for these
contradictory observations is that one or several of the
GFP-hMSH5-bgal fusion products adopt folded confor-
mations that compromise the accessibility of potential
hMSH5 domains to either members of the importin
superfamily transporters or NLS-containing partners.
In order to test whether the 406-KKRR-409 motif par-
ticipates to the nuclear targeting of hMSH5, site-directed
mutagenesis was performed to substitute lysine and
arginine with alanine in the context of the full-length
hMSH5 protein (Figure 6A). The expression of resulting
mutated proteins was assessed by western blot
analysis (Figure 6B) and their subcellular distribution
was analyzed by confocal ﬂuorescence microscopy
(Figure 6C). Mutations in the NLS of hMSH5 did not
signiﬁcantly reduce the nuclear localization of the
resulting mutated proteins, when compared with the
wild-type (percentage of nuclear localization, wt:
14.4±0.03%; m8: 11.1±0.81%; m9: 11.09±1.72%;
m10: 11.74±0.96%). We reasoned that a reduction of
the nuclear activity of hMSH5 NLS motif might not be
detected without inhibiting hMSH5 nuclear export.
Therefore, we analyzed the subcellular localization of the
three NLS-mutated GFP-hMSH5 proteins after LMB
treatment (Figure 6C). GFP-hMSH5 proteins bearing
mutations in the NLS motif accumulated in the nucleus
to a signiﬁcant lesser extent than the wild-type protein
after LMB treatment, which indicated that the nuclear
import of these NLS-mutants is altered. Converting all
the basic amino acids within the NLS to alanine led to a
further signiﬁcant decrease in the nuclear localization of
the corresponding m10 mutant when compared with m8
and m9 mutants, after inhibition of the nuclear export.
These ﬁndings suggested that 406-KKRR-409 motif acts
as a true nuclear localization signal in the context of the
hMSH5 protein and that both pairs of basic amino acids
within this NLS (406K/407K and 408R/409R) contrib-
ute to its nuclear export activity. We also observed that
the addition of LMB induced a slight but signiﬁcant
nuclear enrichment of the m10 mutant, suggesting that
this mutated protein exhibits a residual nuclear import
activity. This observation supported the possibility that
a nuclear targeting domain other than the above-
characterized NLS might contribute to hMSH5 nuclear
import, which was consistent with the fact that the
GFP-hMSH5-[522–834] truncated mutant is able to
enter the nucleus.
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The above data suggested that hMSH5 is a
nucleocytoplasmic shuttling protein exported from the
nucleus through the CRM1 pathway. It is known for
several proteins that nuclear export is a prerequisite for
their degradation (34–36). As a ﬁrst step toward
investigating whether hMSH5 follows a similar fate, we
examined the relationship between its subcellular
localization and its stability. HeLa cells expressing
GFP-hMSH5 were treated with cycloheximide to inhibit
de novo protein synthesis or with DMSO as a control.
Nuclear and cytoplasmic fractions were prepared at the
indicated time points and analyzed by immunoblotting
to assess GFP-hMSH5 levels (Figure 7A). The amount
of cytoplasmic and nuclear GFP-hMSH5 was not
aﬀected by DMSO. The level of the cytoplasmic
GFP-hMSH5 declined by  25% 2h after addition of
Figure 5. Mapping of putative NLS sites in hMSH5. (A) Conservation of the MSH5 NLS sequence (boxed residues) among vertebrates.
(B) Schematic representation of the GFP-bgal protein encoded by the pHM830 vector and of the various fusion proteins encoded by the
pHM830-derived constructs. The basic amino acids within the putative hMSH5 NLS are shown in bold typeface. hMSH5 amino acids at the
boundaries of the regions fused to GFP and b-galactosidase are indicated. (C) Representative confocal microscopy images of HeLa cells expressing:
a, GFP-bgal (negative control); b, GFP-(SV40-LT)NLS-bgal (positive control); c, GFP-hMSH5-[404–411]-bgal; d, GFP-hMSH5-[1–405]-bgal;
e, GFP-hMSH5-[410–549]-bgal; f, GFP-hMSH5-[508–558]-bgal; g, GFP-hMSH5-[550–750]-bgal; h, GFP-hMSH5-[700–834]-bgal (without LMB
treatment); i) GFP-hMSH5-[700–834]-bgal (plus LMB treatment). (D) The percentage of HeLa cells displaying only cytoplasmic (C), nuclear plus
cytoplasmic (NC) or exclusively nuclear (N) GFP staining was determined for the indicated proteins. For each protein, approximately 200 cells were
counted per experiment. Values shown in the bar graph are the means of three independent experiments with standard deviations.
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reduction of the nuclear GFP-hMSH5 (Figure 7A and B).
These data suggested that hMSH5 stability depends on its
subcellular localization and that nuclear localization is
linked with increased destabilization. Degradation of
most cellular proteins proceeds via an energy-dependent
process involving the 26S proteasome that constitutes the
major proteolytic activity in both the cytosol and the
nucleus. Therefore, we examined the eﬀect of the 26S
proteasome inhibitor MG132 on the turnover of
GFP-hMSH5 in both compartments. HeLa transfected
cells were treated with a combination of cycloheximide
and MG132 before analysis of GFP-hMSH5 levels
(Figure 7A and B). The inhibition of the proteasome
resulted in a stabilization of the tagged hMSH5 protein
in both the cytoplasm and the nucleus (Figure 7A and B),
suggesting that both cytoplasmic and nuclear proteasome
can target hMSH5 for degradation.
These data supported the view that CRM1-dependent
nuclear export is not required for hMSH5 eﬃcient degra-
dation. On the contrary, they rather suggested that forcing
localization of hMSH5 within the nucleus would enhance
its destabilization. To verify this hypothesis, transfected
HeLa cells were mock-treated or incubated with LMB,
4h prior to the addition of either cycloheximide or
DMSO. Two hours later, cells were collected and
GFP-hMSH5 levels were subsequently examined
(Figure 7C). Approximately 62±2.9% of the protein
were degraded after cycloheximide treatment when the
cells have been pre-incubated with LMB, while only
23±11% of degradation was observed without LMB
pre-treatment. These observations further supported that
nuclear hMSH5 is much less stable than the cytoplasmic
protein and thereby conﬁrmed that the CRM1 nuclear
export does not favor hMSH5 degradation.
The hMSH5 NLS activity and the masking of the
hMSH5 NES are both involved in determining the
subcellular localization of the hMSH4-hMSH5 complex
Although emerging data indicate that MSH5 can function
independently of MSH4, this MutS homolog is primarily
known to function as a heterodimer with MSH4.
Therefore, we have previously investigated the conse-
quences of the interaction between hMSH4 and hMSH5
on their subcellular distribution (20). We have found that
both hMSH4 and hMSH5 are independently capable
to enter and exit the nucleus. Nevertheless, their
heterodimerization mutually facilitated their nuclear local-
ization. Some ﬁndings have led us to hypothesize that
dimerization might partially impair hMSH5 nuclear
export on the one hand, and facilitate hMSH4 nuclear
import on the other hand (20). To further explore these
assumptions, we took advantage of the identiﬁcation of
hMSH5 NES and NLS motifs and attempted to inves-
tigate the eﬀect of inactivation of these motifs on
the intracellular distribution of the hMSH4-hMSH5
heterodimer. We ﬁrst tested whether GFP-hMSH5
mutated at the four residues critical for the NES activity
(M7 mutant also called GFP-hMSH5-NES
mut) or at the
four residues required for the NLS functionality (m10
mutant or GFP-hMSH5-NLS
mut) was still able to interact
with hMSH4 (Figure 8A). The wild-type GFP-hMSH5
protein and a deletion mutant (GFP-hMSH5-[1–524])
Figure 6. Site-directed mutagenesis of the putative hMSH5 classical monopartite NLS. (A) Amino acids of the hMSH5 NLS that were replaced with
alanine are shown. The names of the resulting mutants are indicated (m8–m10). (B) Lysates from HeLa cells expressing the indicated mutated protein
were analyzed by western blotting with anti-GFP antibodies. (C) Quantitative analysis of the subcellular localization of hMSH5 NLS-mutated fusion
proteins. HeLa cells expressing the indicated GFP fusion proteins were treated or not with LMB before ﬁxation, and examined by confocal
ﬂuorescence microscopy. For each cell, the ﬂuorescence intensities were measured in the entire cell and in the nuclear area, in order to calculate
the N/N+C ratio. As many as 30–35 cells were analyzed per experiment, for each construct and each incubation condition (±LMB). The graph
shows the mean N/N+C values with standard deviations across three independent experiments. Statistically signiﬁcant P-values are indicated.
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(10,20) were also used in interaction assays as positive
and negative control, respectively. Extracts from HeLa
cells, co-expressing the DsRed-hMSH4 protein with
either GFP-hMSH5, GFP-hMSH5-[1–524], GFP-
hMSH5-NES
mut or GFP-hMSH5-NLS
mut, were subjected
to immunoprecipitation with anti-GFP antibodies
(Figure 8A). As expected, the GFP-hMSH5 and
DsRed-hMSH4 proteins were associated in HeLa cells
whereas GFP-hMSH5-[1–524] and DsRed-hMSH4 did
not appear to interact with one another. Interestingly,
mutations of the four consensus residues in the hMSH5
NES were suﬃcient to abolish or, at least, strongly aﬀect
the association between hMSH4 and hMSH5 in our assay.
Figure 7. Analysis of hMSH5 stability in both the cytoplasm and the nucleus. (A) HeLa cells expressing GFP-hMSH5, were treated with either
DMSO, cycloheximide (CHX) or cycloheximide plus MG132. Cells were collected at the indicated time points and subjected to cytoplasmic (left
panel) and nuclear (right panel) fractionation. GFP-hMSH5 levels were assessed using immunoblotting with anti-GFP antibodies. Protein loading for
cytoplasmic and nuclear samples was normalized by western blot for b-tubulin and Lamin B, respectively. b-Tubulin and Lamin B also serve as
cytoplasmic and nuclear markers, respectively. (B) Similar experiments to that presented in (A) were conducted and resulting autoradiographs were
subjected to densitometric analysis by using ImageJ software (version 1. 36b). Cytoplasmic and nuclear GFP-hMSH5 signals were normalized to the
b-tubulin or Lamin B signals, respectively and were expressed as percentage of the initial signal (t=0h). The data shown are mean of the results
from two to three experiments. (C) HeLa cells expressing GFP-hMSH5 were incubated with or without LMB. After 4h, cells were treated by adding
or not cycloheximide for a period of 2h. A that point, whole cell extracts were prepared and equal amount of the various samples were subjected to
western blot analyses with anti-GFP and b-tubulin antibodies (left panels). Densitometric analyses of autoradiographs were performed with ImageJ
software. For each condition, GFP-hMSH5 signal was normalized to the b-tubulin signal and was expressed as percentage of untreated signal.
The mean percentages of normalized GFP-hMSH5 levels with standard deviations across three independent experiments are presented as a bar graph
(right panel).
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appeared unaﬀected by mutagenesis of the hMSH5
NLS. These interaction data are consistent with the fact
that hMSH5 NES (aa 802–811) is located within the
hMSH4-binding domain (aa 731–833), unlike the
hMSH5 NLS (aa 406–409).
The co-expression and interaction of wild-type hMSH5
and hMSH4 proteins in HeLa cells have been shown to
result in a signiﬁcant nuclear enrichment of both of them
(20). Here, we observed that the subcellular distribution
of GFP-hMSH5-NES
mut (Figure 8B, left panel) and
DsRed-hMSH4 (Figure 8B, right panel) was not
Figure 8. Analysis of the subcellular localization of the NES and NLS-mutated hMSH5 proteins when co-expressed with hMSH4. (A) Protein
extracts from HeLa cells co-expressing DsRed-hMSH4 with either GFP-hMSH5 (lanes 1 and 5), GFP-hMSH5-[1–524] (87kDa) (lanes 2 and 6),
GFP-hMSH5-NES
mut (lanes 3 and 7) or GFP-hMSH5-NLS
mut (lanes 4 and 8) were submitted to immunoprecipitation with anti-GFP antibodies
(lanes 1–4) or directly analyzed by immunoblotting, as a control (lanes 5–8). Immunoprecipitates and extracts were immunoblotted with anti-GFP or
anti-MSH4 antibodies (20), as indicated. (B) The subcellular localization of GFP-hMSH5-NES
mut (left panel) and DsRed-hMSH4 (right panel) was
quantitatively analyzed when these proteins were expressed either alone or together in HeLa cells. The graphs represent N/N+C mean values,
calculated as described in ‘Material and Methods’ section and in Figure 1 legend, with standard deviations from three independent experiments.
(C) The same analyses were performed for GFP-hMSH5-NLS
mut (left panel) and DsRed-hMSH4 (right panel) expressed either alone or together in
HeLa cells.
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consistent with interaction data (Figure 8A). We
concluded that some or all of the amino acids required
for hMSH5 nuclear export are also critical for the
binding of hMSH4. This ﬁnding implied that hMSH4
binding could interfere with the accessibility of the
hMSH5 NES to the export machinery, and thus was con-
sistent with the fact that hMSH5 is less sensitive to LMB
when bound to hMSH4 (20).
Although the NLS-mutated hMSH5 protein has
retained its capacity to interact with hMSH4, the
nuclear localization of GFP-hMSH5-NLS
mut remained
almost unchanged when expressed alone or with
DsRed-hMSH4 (Figure 8C, left panel). The nuclear local-
ization of DsRed-hMSH4 was not increased upon
co-expression with GFP-hMSH5-NLS
mut (Figure 8C,
right panel), whereas it is signiﬁcantly increased upon
co-expression with the wild-type GFP-hMSH5 protein
(20). These observations suggested that the hMSH5 NLS
is required for the maximal nuclear localization of the
hMSH4-hMSH5 heterodimer.
Together, these data led us to propose that two
important parameters that play a role in determining
the nuclear localization of the hMSH4-hMSH5 complex
are the reduction of hMSH5 nuclear export upon
heterodimerization and the nuclear targeting activity of
the hMSH5 NLS.
DISCUSSION
Recent ﬁndings strongly support the premise that in
addition to its role in meiotic recombination, hMSH5 is
involved in diﬀerent cellular processes and that
dimerization with hMSH4 is probably not required for
all of its functions. It has been proposed that hMSH5
participates in mitotic DNA recombination and DNA
damage signaling (4). Hence, appropriate regulation of
hMSH5 activity may play a critical role in genomic stabil-
ity. As a ﬁrst step toward analyzing the mechanisms
involved in the control of hMSH5 activity, we investigated
its cellular traﬃcking properties. We determined that
hMSH5 is a nucleocytoplasmic shuttling protein that
can actively enter and exit the nucleus. In agreement
with previous data (20), exogenously expressed hMSH5
was predominantly observed in the cytoplasm. However,
upon inhibition of the CRM1-mediated nuclear export
pathway, hMSH5 accumulated in the nucleus of
transiently (Figure 1) or stably transfected cells
(Supplementary Figure S3). Moreover, various truncated
hMSH5 fusion proteins, expressed at a level comparable
to the GFP-hMSH5 wild-type protein (data not shown),
exhibited subcellular distribution and LMB sensitivity
distinct from that of the full-length protein. These obser-
vations led us to investigate whether hMSH5
possesses intrinsic signals that direct its intracellular
distribution. We identiﬁed the hMSH5 sequence
802LVDKFMKLDL
811 as a functional NES. This conclu-
sion was reached based on three observations. First, the
802–811 sequence perfectly ﬁts the NES consensus.
Hydrophobic residues within this sequence are conserved
among vertebrates and in the plant Arabidopsis thaliana,
which suggests a biological signiﬁcance. Second, the
mutation of large hydrophobic amino acids within this
motif resulted in signiﬁcant nuclear accumulation of
hMSH5 and rendered the protein much less responsive
to LMB treatment (Figure 3 and Supplementary Figure
S3). The mutation of both L809 and L811 residues was
suﬃcient to render hMSH5 almost insensitive to LMB.
Third, the
802LVDKFMKLDL
811 sequence was able to
mediate nuclear export of an export-defective Rev fusion
protein and this eﬀect was abrogated after LMB treatment
or after introducing mutations at L802, F806, L809 and
L811. It has been shown, by using the Rev(1.4)-GFP
nuclear export assay, that diﬀerent NESs can vary
importantly in activity. Nuclear export sequences with
low activity, as in Hdm2 and p53, have been shown to
increase cytoplasmic GFP staining only in the presence
of actinomycin D (24). By contrast, the hMSH5 NES
was able to shift GFP staining to the cytoplasm without
actinomycin D treatment in more than 55% of cells.
Collectively, these data indicate that hMSH5 harbors a
functional NES in its C-terminal region that mediates its
nuclear export through the CRM1-dependent pathway
and they support the possibility that this NES may exert
a strong nuclear export activity.
Analysis of the hMSH5 primary sequence revealed a
cluster of basic amino acids,
406KKRR
409, that was
conserved among vertebrates and resembled a classical
monopartite NLS. This motif was able to promote
nuclear import when fused to a heterologous protein,
albeit to a lesser extent than the strong SV40 LT NLS.
It was also functional in the context of the hMSH5
full-length protein, as assessed by mutagenesis. Indeed,
mutation of the K406/K407 and/or R408/R409 residues
pairs aﬀected nuclear accumulation of the corresponding
mutated proteins in response to LMB, indicating that the
406KKRR
409 peptide motif is crucial for hMSH5 nuclear
import even though it exhibits weak activity when fused to
a heterologous protein (Figure 6 and Supplementary
Figure S3). A variety of proteins are known to contain
multiple NLSs (37–40), including some containing
nonconventional NLSs that do not conform to either clas-
sical monopartite or bipartite motifs (41–43). To deter-
mine whether this is the case for hMSH5, we assessed
the ability of diﬀerent hMSH5 segments to drive nuclear
accumulation of fused GFP-b-galactosidase. Other than
the
406KKRR
409 NLS, we did not identify any additional
nuclear targeting sequences. However, the fact that the
GFP-hMSH5-[522–834] protein was able to enter the
nucleus (Figure 2C) led us to deduce that at least one
site is present between amino acids 522 and 834, that is
seemingly inaccessible in the context of GFP-b-
galactosidase fusion proteins and that corresponds to
either a nonclassical NLS or to an interacting domain
with a NLS-containing partner. Additional investigations
will be necessary to identify this potential nuclear target-
ing domain and to determine whether it functions
independently or cooperatively with the identiﬁed NLS
in the context of the full-length protein.
3668 Nucleic Acids Research, 2010,Vol.38, No. 11LMB treatment did not result in complete nuclear accu-
mulation of hMSH5 (Figure 1 and Supplementary Figure
S3). Likewise, ectopically expressed hMSH5 with
inactivating mutations in the NES did not fully accumu-
late in the nucleus (Figure 3 and Supplementary Figure
S3). There are several mechanisms that may be responsible
for this. A ﬁrst possibility is that eﬃcient nuclear targeting
of hMSH5 requires not only the identiﬁed NLS but also
NLS-containing partners that may be present in limited
amounts relative to the amount of overexpressed hMSH5
fusion protein. A prediction of this assumption is that
fusion of a strong heterologous NLS to hMSH5 should
rescue nuclear import and enhance hMSH5 nuclear local-
ization, at least after LMB treatment. However, we
observed that when expressed in HeLa cells, treated or
not by LMB, the GFP-NLS-hMSH5 protein containing
the strong SV40 LT NLS was only slightly more nuclear
than GFP-hMSH5 (Supplementary Figure S4). In
contrast, fusion of this NLS to b-galactosidase or to
hMSH4 induced a strong increase in the nuclear localiza-
tion of the resulting hybrid proteins (Supplementary
Figure S4). These results did not support the ﬁrst possi-
bility. As proteins that utilize both CRM1-dependent and
independent nuclear export pathways have been described
(44,45), a second hypothesis is that hMSH5 may also be
exported from the nucleus through a currently
unidentiﬁed CRM1-independent pathway. Finally, a
third explanation for the subcellular distribution pattern
of hMSH5 could be that this protein is sequestered in the
cytoplasm by association with either binding partners,
organelles or cytoskeletal ﬁlaments, as has been described
for other proteins (17,46). Further experiments will be
required to distinguish between the two latter possibilities.
However, these ﬁndings provide a basis for the argument
that hMSH5 subcellular movements are subject to an
intricate level of regulation that is reminiscent of what
has been described for other multifunctional proteins,
such as p53 or BRCA1 (17,46).
A link between nucleocytoplasmic shuttling and protein
degradation has been demonstrated for several molecules.
Degradation of most proteins in mammalian cells is
carried out by the 26S proteasome, usually after the
protein has been tagged with a polyubiquitin chain (47).
Although the proteasome system operates in both the
cytoplasm and the nucleus (48), export to the cytoplasm
appears to be required for eﬃcient degradation of several
proteins (35,36,49). We found that nuclear export did not
facilitate degradation of hMSH5. Instead, hMSH5 nuclear
localization appeared to be associated with increased deg-
radation. This was assessed by analysis of hMSH5 levels
in nuclear and cytoplasmic extracts of HeLa cells at dif-
ferent times after treatment with cycloheximide and sup-
ported by the ﬁnding that impairment of nuclear export
with LMB resulted in a decrease in hMSH5 levels in total
cell lysates. Degradation of both cytoplasmic and nuclear
hMSH5 was reduced by treatment with the proteasome
inhibitor MG132. Although ubiquitination of hMSH5
remains to be investigated, these data support the assump-
tion that degradation of hMSH5 occurs via the 26S
proteasome, in both cytoplasmic and nuclear compart-
ments, albeit much more rapidly in the nucleus.
Precedence for nuclear proteasome-mediated
downregulation of proteins (e.g. for p53) has been estab-
lished (50) and it has been proposed that local nuclear
destruction may be crucial for the rapid turn oﬀ of
nuclear pathways.
Taken together, our ﬁndings suggest that both CRM1-
dependent nucleocytoplasmic shuttling and proteasomal
degradation contribute to limit the level of hMSH5 in
the nucleus. Moreover, some of our observations lead us
to speculate that additional mechanisms, such as
cytoplasmic sequestration and/or CRM1-independent
nuclear export, may also be involved in the maintenance
of low levels of nuclear hMSH5. The biological signiﬁ-
cance of the existence of diﬀerent mechanisms by which
to downregulate hMSH5 nuclear content has yet to be
determined. As uncontrolled amounts of hMSH5 in the
nucleus could be deleterious for genomic stability,
multiple means of regulation may be required to prevent
hMSH5-dependent DNA transactions. Nuclear-
cytoplasmic shuttling is necessary to impede the accumu-
lation of certain proteins in the nucleus but it also plays an
essential role in the movement of various proteins between
diﬀerent cellular organelles and structures. In particular,
several shuttling proteins involved in DNA damage repair
and signaling have been shown to travel between distinct
subcellular organelles including the nucleus, mitochondria
and centrosome and this intracellular traﬃcking is
thought to be crucial for the cell to provide an appropriate
DNA damage response (51). Here, we provide evidence
that hMSH5 is a shuttling protein. Whether its
intracellular traﬃcking plays a role in DNA damage sig-
naling and repair is an issue that remains to be addressed.
It appears that hMSH5 could function independently of
or in association with hMSH4. Therefore, it is of interest
to characterize the intracellular traﬃcking properties of
the hMSH4-hMSH5 heterodimer. Oligomerization-
regulated NES/NLS activities have been reported for
several proteins (17,52), and we have shown previously
that dimerization of hMSH4 and hMSH5 promotes the
nuclear localization of both proteins. This may result from
enhanced nuclear import and/or less eﬃcient nuclear
export of these proteins when they form a complex,
since they interact with each other in both cytoplasmic
and nuclear compartments (20). Identiﬁcation of
hMSH5 NES and NLS motifs allowed us to gain a
better understanding of the mechanisms that underlie
the subcellular distribution of the hMSH4-hMSH5
complex. First, the demonstration that the L802, F806,
L809 and L811 residues are required for both hMSH5
NES activity and hMSH4 binding further supports the
previous assumption that heterodimerization enhances
nuclear retention of hMSH5 by masking its NES (20).
Second, our ﬁnding that mutagenesis of the NLS motif
in hMSH5 aﬀects the nuclear localization of the
hMSH4-hMSH5 heterodimer is in agreement with the
hypothesis that interaction between hMSH5 and hMSH4
might enhance hMSH4 nuclear localization via facilitation
of its nuclear import (20). Together, these ﬁndings prompt
us to propose that the hMSH4-hMSH5 complex
translocates to the nucleus via, at least in part, the
hMSH5 NLS and that hMSH4 binding aﬀects the
Nucleic Acids Research, 2010,Vol.38, No. 11 3669export activity of the hMSH5 NES. Our data also suggest
that the hMSH4-hMSH5 heterodimer can still be exported
from the nucleus through the hMSH4 NES. Although it
remains to be determined how the intracellular traﬃcking
of hMSH4-hMSH5 regulates the function of this complex,
we believe that hMSH4 and hMSH5 proteins constitute an
interesting model of reciprocal regulation of nuclear trans-
port by dimerization.
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